Role of immune cells in pancreatic cancer from bench to clinical application: An updated review

BACKGROUND: Pancreatic cancer (PC) remains difficult to treat, despite the recent advances in various anticancer therapies. Immuno-inflammatory response is considered to be a major risk factor for the development of PC in addition to a combination of genetic background and environmental factors. Alt...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Jae Hyuck, Jiang, Yongjian, Pillarisetty, Venu G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5266022/
https://www.ncbi.nlm.nih.gov/pubmed/27930550
http://dx.doi.org/10.1097/MD.0000000000005541

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5266022/
https://www.ncbi.nlm.nih.gov/pubmed/27930550
http://dx.doi.org/10.1097/MD.0000000000005541

Ejemplares similares